Patents Assigned to IncreVet, Inc.
  • Patent number: 12274689
    Abstract: Provided herein are methods of managing feline diabetes, said methods include administering to a feline in need thereof a total daily dosage of about 5 to 50 mg of Compound 1, having the formula: or a pharmaceutically acceptable form thereof. Also provided herein are methods of managing feline diabetes by administering to a feline in need thereof an effective amount of a SGLT inhibitor, wherein said effective amount is no more than 10 to 30% of the dose required to produce an elevated frequency of diarrhea or loose stool in a healthy feline.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: April 15, 2025
    Assignee: IncreVet, Inc.
    Inventors: Michael Hadd, Albert Collinson, Brian Seed